Sleep apnea is a medical condition that affects an estimated 22 million Americans. Typical symptoms of sleep apnea include heavy snoring, excessive daytime sleepiness or fatigue, and difficulty with ...
Earlier this week, the U.S. Department of Justice, representing the Food and Drug Administration and healthcare technology company Philips came to an agreement to no longer sell their sleep therapy or ...
One of the nation's largest makers of machines for sleep apnea sufferers has agreed to pay at least $479 million to compensate customers who bought the devices. Philips Respironics and Koninklijke ...
In 2021, polyester-based polyurethane (PE-PUR) foam used in Philips Respironics ventilators, CPAP and BiPAP machines was found to degrade and cause serious health issues or death, leading to a mass ...
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) is urging caution when using a certain Philips CPAP machine, due to possible safety issues. The agency is alerting patients and health ...
The U.S. Food and Drug Administration issued a safety alert on Tuesday about an “emerging safety issue” with some CPAP machines. According to the FDA, the Philips Respironics’ DreamStation 2 CPAP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback